Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Operating Expenses (2022 - 2023)

Historic Operating Expenses for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $15.0 million.

  • Lexeo Therapeutics' Operating Expenses fell 146.74% to $15.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $68.5 million, marking a year-over-year change of. This contributed to the annual value of $105.8 million for FY2024, which is 5437.36% up from last year.
  • Lexeo Therapeutics' Operating Expenses amounted to $15.0 million in Q4 2023, which was down 146.74% from $20.3 million recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Operating Expenses registered a high of $20.3 million during Q3 2023, and its lowest value of $14.0 million during Q2 2023.